New Research Shows Benefits of Neurostimulation For Migraines

Neurostimulation for Migraine

October 26, 2012

A recent  press release on Yahoo announced some exciting medical research news for chronic migraine sufferers everywhere.  The purpose of the research study, conducted by experts from a medical device company, was to determine the outcome of peripheral nerve stimulation treatment to the occipital nerves in individuals suffering with chronic migraines.

For the study, researchers followed 157 subjects who experienced headaches about 21 days of every month.  The patients received implanted neurostimulation devices and were either placed in an active or control group.  The second group received the activated impulses once the 12-week study concluded.  Among the individuals who received the neurostimulation treatment for 12 weeks, 53 percent of the subjects indicated they were pleased with the improvement in their pain symptoms and indicated a 42 percent increase in relief.  On average, headaches were reduced to 6 occurrences per month.  At the conclusion of the study disability scores, measured by a questionnaire (Migraine Disability Assessment), revealed a 43 percent overall benefit .

The peripheral nerve stimulation treatment used in the research is based on the same technology behind the Omega ™ Migraine procedure performed by the partner physicians of Migraine Treatment Centers of America, to treat patients with chronic migraines.  Neurostimulation has been in use for several decades as a therapy for chronic pain.  By delivering mild electrical impulses to the nerves involved in migraine events, pain signals are interrupted and prevented from reaching the brain.

The lead researcher of the study said, “For the millions who suffer from chronic migraine, these study results are important, as they confirm that peripheral nerve stimulation (PNS) of the occipital nerve may help improve their quality of life and lessen the number of days per month they suffer with this debilitating condition.”

The findings, published in the online October Cephalalgia, the International Headache Society’s journal, came out of a large scale study performed at 15 U.S. medical facilities.  They confirm earlier research studies showing that peripheral nerve stimulation helps chronic migraine patients for whom pharmaceutical or interventional pain management treatments failed.  To learn more about neurostimulation and the Omega ™ Migraine procedure, contact one of the migraine specialists at Migraine Treatment Centers of America.

Previous post:

Next post: